MUMBAI: Sun Pharmaceutical Industries Ltd reported its first quarterly loss in at least 12 years after settling an antitrust case in the US amid a global downturn in the generic-drug business.
India’s biggest drugmaker, founded by billionaire Dilip Shanghvi, posted a total loss of 4.25 billion rupees (US$66.3mil) in the three months ended June 30, the Mumbai-based company said in a filing yesterday.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
